Skip to search formSkip to main contentSkip to account menu

dazoxiben

Known as: Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)- 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Enzyme InhibitorsImidazoles

Narrower (2)

UK 37248dazoxiben hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
The calcium ionophore A23187 induces endothelium‐dependent contractions in femoral arteries from rats with streptozotocin‐induced diabetes
To study the importance of endothelium‐derived contracting factors (EDCFs) in arteries of rats with type I diabetes. 
1990
1990
Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
1990
1990
Prostaglandin redirection by thromboxane synthetase inhibition. Attenuation of myocardial stunning in canine heart.
We have previously reported that inhibition of thromboxane synthesis results in an improvement in postischemic function in… 
1985
1985
Effects of a thromboxane synthetase inhibitor and a thromboxane antagonist on release and activity of thromboxane A2 and prostacyclin in vitro.
Highly Cited
1985
Highly Cited
1985
Nifedipine in the treatment of Raynaud's phenomenon. Evidence for inhibition of platelet activation.
Highly Cited
1985
Highly Cited
1985
Administration of dazoxiben, a selective thromboxane synthetase inhibitor, in the adult respiratory distress syndrome.
Experimental studies suggest that thromboxane A2 could play a role in the pulmonary hypertension of the adult respiratory… 
Highly Cited
1984
Highly Cited
1984
Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.
Recent studies suggest that platelet activation and subsequent thromboxane (TX) A2 release play important roles in certain… 
Highly Cited
1984
Highly Cited
1984
Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
1984
1984
Preliminary observations on treatment of pregnancy-induced hypertension with a thromboxane synthetase inhibitor.
1982
1982
Evidence that thromboxane contributes to ventricular fibrillation induced by reperfusion of the ischaemic myocardium.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)